Stanford University Hospital
Stanford, California, 94305, United States
NCT Number: NCT02912117
Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 Months
Karius, Inc.
Industry
Determining the Etiologic Diagnosis in Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT02282215
Acute Myeloid Leukemia, Agranulocytosis
La Jolla, California, United States
View Trial DetailsNCT00335478
Agranulocytosis, Body Temperature Changes
Portland, Oregon, United States
View Trial DetailsNCT00627393
Agranulocytosis, Cytopenia
Iowa City, Iowa, United States
View Trial Details